
Results
2
Companies that has zero debt on their balance sheet and is forecast to grow at an exponential rate in the future.
2 companies
Krystal Biotech
Market Cap: €10.1b
A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.
1KRYS
€307.80
7D
-1.7%
1Y
142.6%
Corcept Therapeutics
Market Cap: €9.6b
A biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
1CORT
€78.36
7D
-1.7%
1Y
27.1%